Literature DB >> 19185100

Enhanced estrogen-induced proliferation in obese rat endometrium.

Qian Zhang1, Qi Shen, Joseph Celestino, Michael R Milam, Shannon N Westin, Robin A Lacour, Larissa A Meyer, Gregory L Shipley, Peter J A Davies, Lei Deng, Adrienne S McCampbell, Russell R Broaddus, Karen H Lu.   

Abstract

OBJECTIVE: We tested the hypothesis that the proliferative estrogen effect on the endometrium is enhanced in obese vs lean animals. STUDY
DESIGN: Using Zucker fa/fa obese rats and lean control, we examined endometrial cell proliferation and the expression patterns of certain estrogen-regulated proproliferative and antiproliferative genes after short-term treatment with estradiol.
RESULTS: No significant morphologic/histologic difference was seen between the obese rats and the lean rats. Estrogen-induced proproliferative genes cyclin A and c-Myc messenger RNA expression were significantly higher in the endometrium of obese rats compared with those of the lean control. Expression of the antiproliferative gene p27Kip1 was suppressed by estrogen treatment in both obese and lean rats; however, the decrease was more pronounced in obese rats. Estrogen more strongly induced the antiproliferative genes retinaldehyde dehydrogenases 2 and secreted frizzled-related protein 4 in lean rats but had little or no effect in obese rats.
CONCLUSION: Enhancement of estrogen-induced endometrial proproliferative gene expression and suppression of antiproliferative gene expression was seen in the endometrium of obese vs lean animals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185100      PMCID: PMC2880878          DOI: 10.1016/j.ajog.2008.08.064

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  29 in total

Review 1.  The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions.

Authors:  Seunghee Yoon; Rony Seger
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

Review 2.  The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.

Authors:  Katherine L Dunn; Paula S Espino; Bojan Drobic; Shihua He; James R Davie
Journal:  Biochem Cell Biol       Date:  2005-02       Impact factor: 3.626

3.  Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.

Authors:  S Erkanli; F Kayaselcuk; E Kuscu; T Bagis; F Bolat; A Haberal; B Demirhan
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

4.  Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells.

Authors:  Yatrik M Shah; Mariam Al-Dhaheri; Yan Dong; Clement Ip; Frank E Jones; Brian G Rowan
Journal:  Mol Cancer Ther       Date:  2005-08       Impact factor: 6.261

Review 5.  Epidemiology of endometrial neoplasia.

Authors:  D Schottenfeld
Journal:  J Cell Biochem Suppl       Date:  1995

6.  Case-control study of endogenous steroid hormones and endometrial cancer.

Authors:  N Potischman; R N Hoover; L A Brinton; P Siiteri; J F Dorgan; C A Swanson; M L Berman; R Mortel; L B Twiggs; R J Barrett; G D Wilbanks; V Persky; J R Lurain
Journal:  J Natl Cancer Inst       Date:  1996-08-21       Impact factor: 13.506

7.  Diabetes and risk of endometrial cancer: a population-based prospective cohort study.

Authors:  Emilie Friberg; Christos S Mantzoros; Alicja Wolk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

8.  Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.

Authors:  Carolyn K McCourt; David G Mutch; Randall K Gibb; Janet S Rader; Paul J Goodfellow; Kathryn Trinkaus; Matthew A Powell
Journal:  Gynecol Oncol       Date:  2006-11-14       Impact factor: 5.482

9.  Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction.

Authors:  S Baluchamy; N Sankar; A Navaraj; E Moran; B Thimmapaya
Journal:  Oncogene       Date:  2006-07-24       Impact factor: 9.867

10.  Regulation of expression of the retinoic acid-synthesising enzymes retinaldehyde dehydrogenases in the uteri of ovariectomised mice after treatment with oestrogen, gestagen and their combination.

Authors:  Ralph Rühl; Britta Fritzsche; Julien Vermot; Karen Niederreither; Ulrike Neumann; Anja Schmidt; Florian J Schweigert; Pascal Dollé
Journal:  Reprod Fertil Dev       Date:  2006       Impact factor: 2.311

View more
  13 in total

1.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

Review 2.  Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer.

Authors:  Matthew J Carlson; Kristina W Thiel; Shujie Yang; Kimberly K Leslie
Journal:  Discov Med       Date:  2012-09       Impact factor: 2.970

Review 3.  Understanding obesity and endometrial cancer risk: opportunities for prevention.

Authors:  Rosemarie E Schmandt; David A Iglesias; Ngai Na Co; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2011-06-07       Impact factor: 8.661

4.  Prospective evaluation of insulin resistance among endometrial cancer patients.

Authors:  Jennifer K Burzawa; Kathleen M Schmeler; Pamela T Soliman; Larissa A Meyer; Michael W Bevers; Terri L Pustilnik; Matthew L Anderson; Lois M Ramondetta; Guillermo Tortolero-Luna; Diana L Urbauer; Shine Chang; David M Gershenson; Jubilee Brown; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2011-02-16       Impact factor: 8.661

5.  Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression.

Authors:  Wei Zhang; Jo-Hsin Chen; Irene Aguilera-Barrantes; Chung-Wai Shiau; Xiugui Sheng; Li-Shu Wang; Gary D Stoner; Yi-Wen Huang
Journal:  Mol Nutr Food Res       Date:  2016-07-25       Impact factor: 5.914

6.  Chemopreventive effects of metformin on obesity-associated endometrial proliferation.

Authors:  Qian Zhang; Joseph Celestino; Rosemarie Schmandt; Adrienne S McCampbell; Diana L Urbauer; Larissa A Meyer; Jennifer K Burzawa; Marilyn Huang; Melinda S Yates; David Iglesias; Russell R Broaddus; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2013-03-15       Impact factor: 8.661

7.  Skeletal and Uterotrophic Effects of Endoxifen in Female Rats.

Authors:  Anne Gingery; Urszula T Iwaniec; Malayannan Subramaniam; Russell T Turner; Kevin S Pitel; Renee M McGovern; Joel M Reid; Ronald J Marler; James N Ingle; Matthew P Goetz; John R Hawse
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

8.  Associations Between Endometriosis and Gut Microbiota.

Authors:  Agnes Svensson; Louise Brunkwall; Bodil Roth; Marju Orho-Melander; Bodil Ohlsson
Journal:  Reprod Sci       Date:  2021-03-03       Impact factor: 3.060

Review 9.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

10.  Kingiodendron pinnatum, a pharmacologically effective alternative for Saraca asoca in an Ayurvedic preparation, Asokarishta.

Authors:  Adangam Purath Shahid; Nanu Sasidharan; Sasidharan Salini; Jose Padikkala; Nair Meera; Achuthan Chathrattil Raghavamenon; Thekkekara Devassy Babu
Journal:  J Tradit Complement Med       Date:  2017-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.